Fischer Medical Ventures Seeks Shareholder Approval for Rs 1,000 Crore Borrowing Limit

Proposed NCD issuance of up to Rs 350 crore; total borrowing limit expansion to Rs 1,000 crore.

Reader Takeaway: The company is building debt capacity through promoter-backed guarantees, though investors should monitor future interest cost impacts.

What just happened

Fischer Medical Ventures Limited has launched a postal ballot to obtain formal shareholder approval for a series of debt-related resolutions. The company plans to issue Non-Convertible Debentures (NCDs) worth up to Rs 350 crore. To support this, it is seeking permission to increase its total outstanding borrowing limit to Rs 1,000 crore. The resolutions cover the creation of security interests, including a first-ranking pari passu charge on subsidiary assets and a 100% equity pledge of key subsidiaries.

Why this matters

These resolutions provide the necessary legal framework for the company to access capital markets for funding. By securing corporate guarantees from promoter-linked entities like FMV Holdings Pte. Ltd. and Mercatus Capital Pte. Ltd., the firm aims to bolster the credit profile of the proposed NCDs. The requirement to maintain a 2.5x security cover, with strict protocols for top-ups if the cover dips below 2.25x, indicates a structured approach to managing debt obligations.

Risks to watch

Investors should be mindful of the significant related-party exposure, as the corporate guarantees rely on promoter-affiliated firms. Additionally, the leverage profile of the company will shift as it nears the new Rs 1,000 crore debt ceiling. Maintaining the mandated security cover will be a critical operational priority to avoid potential defaults or forced promoter share pledges.

What to track next

The voting process is scheduled to run from October 17, 2026, to November 15, 2026, with results expected by November 17, 2026. Following the outcome, market participants should watch for further board announcements detailing the specific coupon rates, tenure, and subscription terms for the Rs 350 crore NCD issuance.